← Back to Search

Shared Decision Making Tools for Kidney Transplantation

N/A

Waitlist Available

Led By Sumit Mohan, MD, MPH

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Receiving hemodialysis at one of the following dialysis clinics: Fresenius Kidney Care City Dialysis, DaVita Kidney Care Haven Dialysis, DaVita Melrose Dialysis, DaVita Highbridge Dialysis, Rogosin Institute East Side Dialysis Unit, Rogosin Institute West Side Dialysis Unit

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end of intervention/at completion of letter delivery (4-6 months)

Awards & highlights

Study Summary

This trial aims to empower kidney patients to make informed decisions about transplant & reduce inequalities in access to transplants.

Who is the study for?

This trial is for adults on hemodialysis at select clinics in New York and Cleveland who are either on a kidney transplant waitlist or undergoing evaluation at CU/NYPH Transplant Center or the Cleveland Clinic. Participants must speak English or Spanish.Check my eligibility

What is being tested?

The study aims to improve kidney transplantation rates by using educational materials to enhance decision-making between patients and providers over a period of 6-12 months, focusing also on reducing disparities in access.See study design

What are the potential side effects?

Since this trial involves patient letters and provider educational materials rather than medical treatments, there are no direct physical side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am undergoing hemodialysis at a specified clinic.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end of intervention/at completion of letter delivery (4-6 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end of intervention/at completion of letter delivery (4-6 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and end of intervention/at completion of letter delivery (4-6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in donor kidney preferences

Change in frequency of shared decision-making conversations

Change in patient knowledge of individual waitlist status

Secondary outcome measures

Change in dialysis provider attitudes, as measured on provider survey

Provider assessment of patient letters, as measured on provider survey

Trial Design

2Treatment groups

Experimental Treatment

Group I: ProvidersExperimental Treatment1 Intervention

Dialysis providers will receive educational material about the kidney transplantation and waitlisting process.

Group II: PatientsExperimental Treatment1 Intervention

Dialysis patients will receive letters with information about their status within the kidney transplantation and waitlisting process.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Kidney FoundationOTHER

28 Previous Clinical Trials

84,567 Total Patients Enrolled

2 Trials studying Kidney Failure

1,252 Patients Enrolled for Kidney Failure

Columbia UniversityLead Sponsor

1,432 Previous Clinical Trials

2,460,523 Total Patients Enrolled

1 Trials studying Kidney Failure

2,094 Patients Enrolled for Kidney Failure

Kidney Transplant CollaborativeUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment currently admit participants?

"According to the information present on clinicaltrials.gov, this trial is not actively recruiting participants at this time. The study was initially posted in November of 2023 and revised two weeks ago; however, 311 other trials are currently accepting enrolment from volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using Shared Decision Making to Improve Kidney Transplantation Rates

Sumit Mohan, MD 2024. "Using Shared Decision Making to Improve Kidney Transplantation Rates". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06141499.

All > Kidney Transplant